The cervical lymph node contributes to peripheral inflammation related to Parkinson’s disease

[1]  D. Otzen,et al.  Polarized α-synuclein trafficking and transcytosis across brain endothelial cells via Rab7-decorated carriers , 2022, Fluids and Barriers of the CNS.

[2]  Y. Li,et al.  Parkinson's Disease Derived Exosomes Aggravate Neuropathology in SNCA*A53T Mice , 2022, Annals of neurology.

[3]  M. Tansey,et al.  Inflammation and immune dysfunction in Parkinson disease , 2022, Nature Reviews Immunology.

[4]  R. Chan,et al.  α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson’s disease , 2022, Journal of Neuroinflammation.

[5]  C. Pariante,et al.  From dried bear bile to molecular investigation: A systematic review of the effect of bile acids on cell apoptosis, oxidative stress and inflammation in the brain, across pre-clinical models of neurological, neurodegenerative and neuropsychiatric disorders , 2021, Brain, Behavior, and Immunity.

[6]  H. Zoghbi,et al.  Parkinson's Disease Genetics and Pathophysiology. , 2021, Annual review of neuroscience.

[7]  M. Tansey,et al.  Genetic and Environmental Factors in Parkinson's Disease Converge on Immune Function and Inflammation , 2020, Movement disorders : official journal of the Movement Disorder Society.

[8]  E. Dardiotis,et al.  Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease , 2020, International journal of molecular sciences.

[9]  G. Forloni,et al.  Peripheral inflammation exacerbates α‐synuclein toxicity and neuropathology in Parkinson's models , 2020, Neuropathology and applied neurobiology.

[10]  C. Hetz,et al.  Mechanisms, regulation and functions of the unfolded protein response , 2020, Nature Reviews Molecular Cell Biology.

[11]  J. Jankovic,et al.  Parkinson disease and the immune system — associations, mechanisms and therapeutics , 2020, Nature Reviews Neurology.

[12]  Victor G. Martinez,et al.  Fibroblastic Reticular Cells Control Conduit Matrix Deposition during Lymph Node Expansion , 2019, Cell reports.

[13]  Magdalena Kusaczuk.  Tauroursodeoxycholate—Bile Acid with Chaperoning Activity: Molecular and Cellular Effects and Therapeutic Perspectives , 2019, Cells.

[14]  Nikhil Panicker,et al.  Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson’s Disease , 2019, Neuron.

[15]  J. Kassubek,et al.  Increased Immune Activation by Pathologic α‐Synuclein in Parkinson's Disease , 2019, Annals of neurology.

[16]  G. Koh,et al.  Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid , 2019, Nature.

[17]  Paolo Eusebi,et al.  CSF and blood biomarkers for Parkinson's disease , 2019, The Lancet Neurology.

[18]  E. Colla.  Linking the Endoplasmic Reticulum to Parkinson’s Disease and Alpha-Synucleinopathy , 2019, Front. Neurosci..

[19]  T. Feng,et al.  Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease , 2019, Translational Neurodegeneration.

[20]  G. van Loo,et al.  Inflammasomes in neuroinflammatory and neurodegenerative diseases , 2019, EMBO molecular medicine.

[21]  Ming Lu,et al.  Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein , 2019, Translational Neurodegeneration.

[22]  D. Holtzman,et al.  Dural lymphatics regulate clearance of extracellular tau from the CNS , 2019, Molecular Neurodegeneration.

[23]  Tessandra H Stewart,et al.  New windows into the brain: Central nervous system-derived extracellular vesicles in blood , 2019, Progress in Neurobiology.

[24]  Jonathan Kipnis,et al.  The Meningeal Lymphatic System: A New Player in Neurophysiology , 2018, Neuron.

[25]  Christopher C. Overall,et al.  CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature , 2018, Nature Neuroscience.

[26]  Christopher C. Overall,et al.  Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease , 2018, Nature.

[27]  Scott T. Acton,et al.  Functional aspects of meningeal lymphatics in aging and Alzheimer’s disease , 2018, Nature.

[28]  Peng Wang,et al.  The genetics of Parkinson disease , 2018, Ageing Research Reviews.

[29]  C. Bertram,et al.  Lymphatic System Flows. , 2018, Annual review of fluid mechanics.

[30]  C. Hetz,et al.  ER stress and the unfolded protein response in neurodegeneration , 2017, Nature Reviews Neurology.

[31]  D. Krainc,et al.  α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies , 2017, Nature Medicine.

[32]  J. Volkmann,et al.  Parkinson disease , 2017, Nature Reviews Disease Primers.

[33]  Y. Loh,et al.  Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease: A Systematic Review and Meta-analysis. , 2016, JAMA neurology.

[34]  A. Louveau,et al.  How Do Meningeal Lymphatic Vessels Drain the CNS? , 2016, Trends in Neurosciences.

[35]  Randal J. Kaufman,et al.  The unfolded protein response in immunity and inflammation , 2016, Nature Reviews Immunology.

[36]  Tessandra H Stewart,et al.  Alpha‐Synuclein as a Biomarker for Parkinson's Disease , 2016, Brain pathology.

[37]  P. Luciw,et al.  NOD1/NOD2 signaling links ER stress with inflammation , 2016, Nature.

[38]  Xia Zhang,et al.  Role of neuroinflammation in neurodegenerative diseases (Review) , 2016, Molecular medicine reports.

[39]  P. Kallunki,et al.  Development of Passive Immunotherapies for Synucleinopathies , 2016, Movement disorders : official journal of the Movement Disorder Society.

[40]  Mohammad Jafarnejad,et al.  Modeling Lymph Flow and Fluid Exchange with Blood Vessels in Lymph Nodes. , 2015, Lymphatic research and biology.

[41]  J. Gugenheim,et al.  ER stress induces NLRP3 inflammasome activation and hepatocyte death , 2015, Cell Death and Disease.

[42]  Michael Detmar,et al.  A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules , 2015 .

[43]  Anne L. Fletcher,et al.  Lymph node fibroblastic reticular cells in health and disease , 2015, Nature Reviews Immunology.

[44]  L. Glimcher,et al.  Endoplasmic reticulum stress in immunity. , 2015, Annual review of immunology.

[45]  W. Banks,et al.  Alpha synuclein is transported into and out of the brain by the blood–brain barrier , 2014, Peptides.

[46]  J. Kassubek,et al.  Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients , 2014, Acta Neuropathologica.

[47]  R. Kaufman,et al.  The impact of the endoplasmic reticulum protein-folding environment on cancer development , 2014, Nature Reviews Cancer.

[48]  Wei Zheng,et al.  Brain disposition of α-Synuclein: roles of brain barrier systems and implications for Parkinson’s disease , 2014, Fluids and Barriers of the CNS.

[49]  T. J. Cook,et al.  Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease , 2014, Acta Neuropathologica.

[50]  Chuong B. Do,et al.  Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease , 2014, Nature Genetics.

[51]  J. Trojanowski,et al.  Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies , 2013, Nature Reviews Neuroscience.

[52]  M. Xilouri,et al.  Alpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship , 2013, Molecular Neurobiology.

[53]  Ronald N. Germain,et al.  A Spatially-Organized Multicellular Innate Immune Response in Lymph Nodes Limits Systemic Pathogen Spread , 2012, Cell.

[54]  M. Herrero,et al.  IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease , 2012, Cell Death and Disease.

[55]  M. Herrero,et al.  IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease , 2011, Cell Death and Disease.

[56]  Xi Chen,et al.  TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages , 2010, Nature Immunology.

[57]  G. Sainte-Marie,et al.  The Lymph Node Revisited: Development, Morphology, Functioning, and Role in Triggering Primary Immune Responses , 2010, Anatomical record.

[58]  O. Lindvall,et al.  Research in motion: the enigma of Parkinson's disease pathology spread , 2008, Nature Reviews Neuroscience.

[59]  Houeto Jean-Luc.  [Parkinson's disease]. , 2022, La Revue du praticien.

[60]  Belinda Wilson,et al.  Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[61]  M. Chesselet,et al.  Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[62]  Andre Parent,et al.  Presence of reactive microglia in monkey substantia nigra years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine administration , 2003, Annals of neurology.

[63]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[64]  J. Trojanowski,et al.  Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. , 2002, Neuron.

[65]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[66]  N. Ogawa,et al.  Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion , 1997, Journal of Neuroscience Methods.

[67]  S E Ide,et al.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.

[68]  P. Mcgeer,et al.  Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.